Care and management of diabetic nephropathy (moderate to advanced renal involvement)

EDTNA-ERCA Journal

Volumn 30, Issue 3, 2004, Pages 120-123

  Thomas, Nicola ^a,b  

^a ST HELIER HOSPITAL   (United Kingdom)

^b CITY UNIVERSITY   (United Kingdom)

Author keywords

Diabetic nephropathy; Management; Recommendations; Risk factors

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; LIPID;

COUGHING; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EVALUATION; HEALTH CARE MANAGEMENT; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; PATIENT REFERRAL; REVIEW; RISK FACTOR;

EID: 12144268590     PISSN: 1019083X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2004.tb00348.x     Document Type: Review

References (17)

1. Audit Commission Testing Times, a review of diabetes services in England and Wales. 2000 Audit Commission, London.
2. Roderick, et al Predicting future demand in England, a simulation model of renal replacement therapy in the Fifth Annual Report of the UK Renal Registry 2002.
3. UK Renal Registry The Fifth Annual Report of the UK Renal Registry, Bristol UK 2002
4. Diabetes Control and Complication Trail Research Group (DCCT) The effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes and Complications Trial Kidney International 1995 June; 47 (6): 1703-20
5. UK Prospective Diabetes Study Group. Tight Blood Pressure Control and the Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes (UKPDS) 38 British Medical Journal 1998; 317: 703-713
6. Koppiker N, Feehally J, Raymond N, Abrams KR, Burden AC. Rate of decline in renal function in Indo-Asians and Whites with diabetic nephropathy. Diabetic Medicine 1998; 15 (1): 60-5.
7. Sikka R, Waters J, Moore W, Sutton DR, Herman WH, Aubert RE. Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes. Diabetes Care 1999; 22 (1): 1-6
8. Craig KJ, Donovan K, Munnery M, Owens DR, Williams JD, Phillips AO. Identification and management of diabetic nephropathy in the diabetes clinic. Diabetes Care 2003; 26 (6): 1806-11
9. ACE Inhibitors in Diabetic Nephropathy Trialist Group. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta analysis of individual patient data. Annals of International Medicine 2001; 134: 370-9
10. UK Prospective Diabetes Study Group (UKPDS) Tight blood pressure control and risk of macrovascular and microvascular complications in Type II diabetes. UKPDS 38. British Medical Journal 1998; 317: 703-13.
11. National Service Framework for Diabetes: Delivery Strategy 2003 see www.doh.gov.uk/nsf/diabetes
12. NICE Appraisal report: Diabetes-Patient education models 2003 see www.nice.org.uk
13. Bradshaw C, et al Can we improve the education for Type II diabetes patients in general practice? Practical Diabetes International 1999; 16 (8): 241-5.
14. Scottish Intercollegiate Guidelines network Management of diabetes SIGN Publication No. 55 2001 see www.sign.ac.uk
15. NICE Guideline Management of Type 2 Diabetes-Renal disease, prevention and early management 2002 see www.nice.org.uk
16. Renal Association Treatment of adults and children with renal failure. Standards and audit measures. Royal College of Physicians, London. 2002 see www.renal.org.uk
17. Department of Health Renal National Service Framework (Part One), Department of Health, London. 2004 see www.doh.gov.uk/nsf/renal